Arkolith/Insider Trading/TWST/Form 4

Leproust Emily M.

Chief Executive Officer, DirectorTwist Bioscience Corp (TWST) · full profile →Form 4 · filed Apr 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$631K
Net Open-Market Flow
-$631K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Sell(S)8K$65.28$516K859K
Apr 22, 2026Option exercise(M)8K$8.82$71K867K
Apr 22, 2026Sell(S)151$66.00$10K859K
Apr 21, 2026Option exercise(M)2K$8.82$14K860K
Apr 21, 2026Sell(S)2K$65.01$105K859K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 22, 2026Option exercise(M)8K—$0141K
Apr 21, 2026Option exercise(M)2K—$0149K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-005005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML